ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Asthma Drugs Market Research 2021-2026 by Medication, Administration, Source, Organization, Application, Geography, Competitive Analysis and the Impact of Covid-19 - ResearchAndMarkets.com

August 20, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Aug 20, 2021--

The “Global Asthma Drugs Market (2021-2026) by Medication, Administration, Source, Organization, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Asthma Drugs Market is estimated to be USD 15.6 Bn in 2021 and is expected to reach USD 23.6 Bn by 2026, growing at a CAGR of 8.6%.

Market Dynamics

ADVERTISEMENT

The growing incidence of asthma & other breathing syndromes is one of the significant elements increasing the market’s progress. Increasing awareness among the population about the accessibility of asthma therapeutics and the growth of blend remedies for the medication of respiratory disorders is another expansion factor for the market.

Some of the other aspects that drive the market are medical sciences development, cumulative healthcare expenditures, widespread research, and upgrades in healthcare structure. Though, stringent government supervisory necessity for the approval of asthma drugs, patent termination of the drugs, and the drugs indicating side effects restrict the market growth.

Market Segmentation

  • By medication, the market is classified as quick-relief medications, long-term control medications, and others. Amongst all, the long-term control medications segment is estimated to hold the highest market share during the forecast period.
  • By Administration, the market is classified as tablets and capsules, liquids, inhalers, injections, and sprays and powders. Amongst all, the tablets and capsules segment is estimated to hold the highest market share during the forecast period.
  • By Source, the market is classified as environment and generic. Amongst the two, the generic segment is estimated to hold the highest market share during the forecast period.
  • By Organization, the market is classified as private and public. Amongst the two, the public segment is estimated to hold the highest market share during the forecast period.
  • By Application, the market is classified as pediatric, adult, and adolescent. Amongst all, the adults segment is estimated to hold the highest market share during the forecast period.

Recent Developments

  • OMRON Healthcare launches a wheeze detection device to pre-empt asthma attacks in kids. - 3rd December 2020
  • Teva Pharmaceutical Industries Launches Two Digital Inhalers For Asthma Patients. - 22nd September 2020

ADVERTISEMENT

Company Profiles

Some of the companies covered in this report are GlaxoSmithKline, Pfizer, Vectura Group, Boehringer Ingelheim, Roche, Novartis AG, Merck & Co Inc, etc.

Key Topics Covered:

1 Report Description

1.1 Study Objectives

1.2 Market Definition

1.3 Currency

1.4 Years Considered

1.5 Language

1.6 Key Shareholders

2 Research Methodology

2.1 Research Process

2.2 Data Collection and Validation

2.3 Market Size Estimation

2.4 Assumptions of the Study

2.5 Limitations of the Study

3 Executive Summary

3.1 Introduction

3.2 Market Size and Segmentation

3.3 Market Outlook

4 Market Influencers

4.1 Drivers

4.1.1 Growing Prevalence of Asthma

4.1.2 Increasing Acceptance of Asthma Drugs with Approval from FDA

4.1.3 Government Initiatives Fuels the Awareness of Asthma Drugs

4.2 Restraints

4.2.1 Expiry of Patent Drugs

4.2.2 High Penetration of Generic Drugs

4.3 Opportunities

4.3.1 Technological Advancements in the Development of Asthma Drugs

4.3.2 Introduction of Generic Drugs in Developing Regions

4.4 Challenges

4.4.1 Stringent Government Regulations for the Approval of Asthma Drugs

4.5 Trends

5 Market Analysis

5.1 Regulatory Scenario

5.2 Porter’s Five Forces Analysis

5.3 Impact of COVID-19

5.4 Ansoff Matrix Analysis

6 Global Asthma Drugs Market, By Medication

6.1 Introduction

6.2 Quick-Relief Medications

6.3 Long-Term Control Medications

6.4 Others

7 Global Asthma Drugs Market, By Administration

7.1 Introduction

7.2 Tablets And Capsules

7.3 Liquids

7.4 Inhalers

7.5 Injections

7.6 Sprays And Powders

8 Global Asthma Drugs Market, By Source

8.1 Introduction

8.2 Environmental

8.3 Generic

9 Global Asthma Drugs Market, By Organization

9.1 Introduction

9.2 Private

9.3 Public

10 Global Asthma Drugs Market, By Application

10.1 Introduction

10.2 Pediatric

10.3 Adults

10.4 Adolescent

11 Global Asthma Drugs Market, By Geography

12 Competitive Landscape

12.1 Competitive Quadrant

12.2 Market Share Analysis

12.3 Strategic Initiatives

13 Company Profiles

  • Aerocrine AB
  • AMIKO Digital Health
  • AstraZeneca
  • BEXIMCO Pharmaceuticals
  • Boehringer Ingelheim
  • Chiesi Farmaceutici S.p.A.
  • Cipla Inc
  • GlaxoSmithKline,
  • H&T Presspart
  • Merck & Co Inc
  • Mundipharma
  • Novartis AG
  • Omron Healthcare
  • PARI Medical Holding
  • Pfizer
  • PNEUMA Respiratory
  • Roche Holding AG
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd
  • Vectura Group

For more information about this report visit https://www.researchandmarkets.com/r/4zu43q

View source version on businesswire.com:https://www.businesswire.com/news/home/20210820005124/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 08/20/2021 06:10 AM/DISC: 08/20/2021 06:11 AM

http://www.businesswire.com/news/home/20210820005124/en